Ticker Details
Protagonist Therapeutics, Inc. Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
IPO Date:	August 11, 2016
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.17B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 2.82%
Avg Daily Range (30 D):	$1.58 | 1.92%
Avg Daily Range (90 D):	$1.46 | 1.76%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	3,193
Avg Institutional Trade:	$3.18M
Avg Institutional Trade (30 D):	$5.05M
Avg Institutional Trade (90 D):	$6.9M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.73M
Avg Closing Trade (30 D):	$9.72M
Avg Closing Trade (90 D):	$14.41M
Avg Closing Volume:	148.3K

News

Oct 23, 2025 @ 6:25 PM Moody Aldrich Dumps Entire Stake in Chart Industri... Source: Adam Palasciano

Oct 21, 2025 @ 9:03 PM Moody Aldrich Liquidates Entire Stake in PLMR Wort... Source: Adam Palasciano

Oct 15, 2025 @ 9:20 AM This 2.7%-Yielding Dividend King Remains One of th... Source: Matt Dilallo

Oct 14, 2025 @ 12:51 PM Johnson & Johnson To Separate Orthopedics Business... Source: Vandana Singh

Oct 13, 2025 @ 2:30 PM FDA Adds New Warning For Johnson & Johnson's Cance... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.62	$-.55
Diluted EPS		$-.62	$-.55
Revenue		$4.71M	$5.55M
Gross Profit
Net Income / Loss		$-39.34M	$-34.77M
Operating Income / Loss		$-46.42M	$-42.04M
Cost of Revenue
Net Cash Flow		$-54.83M	$28.96M
PE Ratio